IFG Advisors LLC Invests $200,000 in UnitedHealth Group Incorporated (NYSE:UNH)

IFG Advisors LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the 1st quarter, Holdings Channel.com reports. The fund acquired 382 shares of the healthcare conglomerate’s stock, valued at approximately $200,000.

Several other institutional investors and hedge funds have also modified their holdings of the business. Capital & Planning LLC boosted its position in UnitedHealth Group by 19.2% during the 4th quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate’s stock worth $248,000 after acquiring an additional 79 shares during the last quarter. Brighton Jones LLC boosted its position in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after acquiring an additional 28,231 shares during the last quarter. Union Bancaire Privee UBP SA acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $27,233,000. Revolve Wealth Partners LLC boosted its position in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after acquiring an additional 2,324 shares during the last quarter. Finally, Cyr Financial Inc. boosted its position in UnitedHealth Group by 11.1% during the 4th quarter. Cyr Financial Inc. now owns 1,515 shares of the healthcare conglomerate’s stock worth $766,000 after acquiring an additional 151 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Stephen J. Hemsley bought 86,700 shares of the firm’s stock in a transaction on Friday, May 16th. The shares were purchased at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the transaction, the chief executive officer now directly owns 679,493 shares in the company, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Timothy Patrick Flynn bought 1,533 shares of the firm’s stock in a transaction on Wednesday, May 14th. The stock was acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the transaction, the director now owns 6,033 shares of the company’s stock, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 109,408 shares of company stock worth $31,607,768. Company insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

UNH has been the subject of a number of recent research reports. Royal Bank of Canada reduced their price target on UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating for the company in a research report on Friday, May 16th. Wall Street Zen cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Saturday, May 24th. Erste Group Bank cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, April 30th. JPMorgan Chase & Co. dropped their price objective on UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating on the stock in a research note on Thursday, May 15th. Finally, Hsbc Global Res cut UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, May 21st. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $441.87.

UnitedHealth Group Stock Up 1.0%

UNH opened at $301.08 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The company has a market capitalization of $273.12 billion, a P/E ratio of 19.42, a P/E/G ratio of 1.37 and a beta of 0.56. The stock has a fifty day moving average of $430.87 and a 200-day moving average of $494.23.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the previous year, the business posted $6.91 EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.